US Stock MarketDetailed Quotes

Purple Biotech (PPBT)

Watchlist
  • 0.6544
  • +0.0473+7.79%
Close Jan 22 15:57 ET
  • 0.6109
  • -0.0435-6.65%
Pre 08:00 ET
5.91MMarket Cap-0.51P/E (TTM)

Purple Biotech (PPBT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-35.91%1.37M
-62.04%1.24M
-68.52%1.41M
-51.49%10.8M
-83.79%1.02M
-62.88%2.13M
-36.59%3.26M
-12.81%4.47M
-1.47%22.27M
-5.06%6.27M
Selling and administrative expenses
-0.64%780K
-21.04%683K
-38.06%646K
-39.41%2.94M
-50.95%310K
-32.21%785K
-39.51%865K
-35.78%1.04M
-18.75%4.84M
-56.71%632K
-General and administrative expense
----
----
----
-39.41%2.94M
----
----
----
----
-18.75%4.84M
----
Research and development costs
-56.45%587K
-76.87%553K
-77.80%760K
-55.27%7.62M
-91.26%458K
-70.63%1.35M
-35.47%2.39M
-2.14%3.42M
4.38%17.03M
8.76%5.24M
Depreciation amortization depletion
----
----
----
-5.58%186K
----
----
----
----
-1.99%197K
----
-Depreciation and amortization
----
----
----
-5.58%186K
----
----
----
----
-1.99%197K
----
Other operating expenses
----
----
----
-68.37%62K
----
----
----
----
63.33%196K
----
Operating profit
35.91%-1.37M
62.04%-1.24M
68.52%-1.41M
51.49%-10.8M
83.79%-1.02M
62.88%-2.13M
36.59%-3.26M
12.81%-4.47M
1.47%-22.27M
5.06%-6.27M
Net non-operating interest income expense
130.97%118K
-24.74%73K
-75.64%19K
87.58%-212K
97.22%-72K
-155.06%-381K
488.00%97K
-64.38%78K
-418.47%-1.71M
-1,133.07%-2.59M
Non-operating interest income
-5.38%123K
-39.67%73K
-43.16%54K
-45.15%260K
76.06%-152K
-81.64%130K
-1.63%121K
-65.83%95K
-10.90%474K
-556.83%-635K
Non-operating interest expense
-99.02%5K
--0
105.88%35K
-26.79%41K
-205.99%-511K
3,093.75%511K
-83.78%24K
-71.19%17K
-16.42%56K
-307.32%-167K
Total other finance cost
----
----
----
-79.72%431K
----
----
----
----
3,092.96%2.13M
----
Other net income (expense)
-103.03%-56K
-90.05%74K
53.38%931K
-6.62%3.74M
673K
1.85M
744K
607K
1,203.26%4M
Gain on sale of security
-103.03%-56K
-92.18%74K
53.38%931K
-1.57%3.94M
--673K
--1.85M
--946K
--607K
1,203.26%4M
----
Special income (charges)
--0
--0
----
---202K
--0
--0
---202K
----
--0
--0
-Write off
--0
--0
----
--202K
--0
--0
--202K
----
--0
--0
Income before tax
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
Income tax
Net income
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
Net income continuous Operations
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
Minority interest income
60.00%-2K
60.00%-4K
84.21%-3K
59.79%-39K
83.87%-5K
73.68%-5K
54.55%-10K
24.00%-19K
-5.43%-97K
3.13%-31K
Net income attributable to the parent company
-96.53%-1.3M
54.89%-1.09M
87.96%-453K
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-96.53%-1.3M
54.89%-1.09M
87.96%-453K
63.58%-7.24M
91.51%-410K
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
Basic earnings per share
50.00%-0.2
77.78%-0.4
93.93%-34
-145.87%-44.158
95.46%-0.1586
91.36%-0.4
64.00%-1.8
-11,100.00%-560
25.07%-17.96
47.12%-3.49
Diluted earnings per share
50.00%-0.2
77.78%-0.4
93.93%-34
-177.84%-49.9
71.35%-1
91.36%-0.4
64.00%-1.8
-11,100.00%-560
25.07%-17.96
47.12%-3.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -35.91%1.37M-62.04%1.24M-68.52%1.41M-51.49%10.8M-83.79%1.02M-62.88%2.13M-36.59%3.26M-12.81%4.47M-1.47%22.27M-5.06%6.27M
Selling and administrative expenses -0.64%780K-21.04%683K-38.06%646K-39.41%2.94M-50.95%310K-32.21%785K-39.51%865K-35.78%1.04M-18.75%4.84M-56.71%632K
-General and administrative expense -------------39.41%2.94M-----------------18.75%4.84M----
Research and development costs -56.45%587K-76.87%553K-77.80%760K-55.27%7.62M-91.26%458K-70.63%1.35M-35.47%2.39M-2.14%3.42M4.38%17.03M8.76%5.24M
Depreciation amortization depletion -------------5.58%186K-----------------1.99%197K----
-Depreciation and amortization -------------5.58%186K-----------------1.99%197K----
Other operating expenses -------------68.37%62K----------------63.33%196K----
Operating profit 35.91%-1.37M62.04%-1.24M68.52%-1.41M51.49%-10.8M83.79%-1.02M62.88%-2.13M36.59%-3.26M12.81%-4.47M1.47%-22.27M5.06%-6.27M
Net non-operating interest income expense 130.97%118K-24.74%73K-75.64%19K87.58%-212K97.22%-72K-155.06%-381K488.00%97K-64.38%78K-418.47%-1.71M-1,133.07%-2.59M
Non-operating interest income -5.38%123K-39.67%73K-43.16%54K-45.15%260K76.06%-152K-81.64%130K-1.63%121K-65.83%95K-10.90%474K-556.83%-635K
Non-operating interest expense -99.02%5K--0105.88%35K-26.79%41K-205.99%-511K3,093.75%511K-83.78%24K-71.19%17K-16.42%56K-307.32%-167K
Total other finance cost -------------79.72%431K----------------3,092.96%2.13M----
Other net income (expense) -103.03%-56K-90.05%74K53.38%931K-6.62%3.74M673K1.85M744K607K1,203.26%4M
Gain on sale of security -103.03%-56K-92.18%74K53.38%931K-1.57%3.94M--673K--1.85M--946K--607K1,203.26%4M----
Special income (charges) --0--0-------202K--0--0---202K------0--0
-Write off --0--0------202K--0--0--202K------0--0
Income before tax -95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M
Income tax
Net income -95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M
Net income continuous Operations -95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M
Minority interest income 60.00%-2K60.00%-4K84.21%-3K59.79%-39K83.87%-5K73.68%-5K54.55%-10K24.00%-19K-5.43%-97K3.13%-31K
Net income attributable to the parent company -96.53%-1.3M54.89%-1.09M87.96%-453K63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -96.53%-1.3M54.89%-1.09M87.96%-453K63.58%-7.24M91.51%-410K86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M
Basic earnings per share 50.00%-0.277.78%-0.493.93%-34-145.87%-44.15895.46%-0.158691.36%-0.464.00%-1.8-11,100.00%-56025.07%-17.9647.12%-3.49
Diluted earnings per share 50.00%-0.277.78%-0.493.93%-34-177.84%-49.971.35%-191.36%-0.464.00%-1.8-11,100.00%-56025.07%-17.9647.12%-3.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More